IBM opens drug discovery database to the NIH

12/13/2011 | Pharmaceutical Business Review Online · iHealthBeat

IBM will open its database of about 2.4 million chemical compounds to the NIH for research. AstraZeneca, Bristol-Myers Squibb, DuPont and Pfizer collaborated with IBM to compile the database based on millions of patent filings and journal abstracts published between 1976 and 2000.

View Full Article in:

Pharmaceutical Business Review Online · iHealthBeat

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD